With a market capitalization (market cap) of $1.57B — a measure of how much the company is worth — Forte Biosciences, Inc. is the 2265th most valuable company in Healthcare as of August 10, 2026. Shares trade at $76.79, down +0.05% on the day.
of 2,573
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.
Visit websiteAs of August 10, 2026, Forte Biosciences, Inc. (FBRX) is worth $1.57B — this is its market capitalization, the total value of all its outstanding shares.
Forte Biosciences, Inc.’s market cap is $1.57B, which ranks it #2265 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Forte Biosciences, Inc. (FBRX) shares trade at $76.79, down 0.05% on the day, as of August 10, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025